Bitterfeld-Wolfen/Leipzig (Germany) – 26 June 2008. The Annual General Meeting of Q-Cells AG today (Thursday) adopted all of the presented items on the agenda by a large majority. In addition to approving retention of all the net income for 2007 to strengthen the capital base and fund further growth, the shareholders agreed to a possible raising of option and/or convertible bonds in the aggregate principal amount of up to € 5 billion.
The Annual General Meeting also approved the merger between Q-Cells AG and Q-Cells Österreich AG and to change the company’s legal form into a European Company (SE). Since the relevant employee agreement has already been concluded and the merger plan notarised, the change of legal form will take effect with registration with the commercial register. The Annual General Meeting also granted approval of the actions of the Executive Board members and Supervisory Board members for fiscal year 2007.